Savara Pharmaceuticals
SVRA
#6594
Rank
โ‚ฌ0.52 B
Marketcap
3,07ย โ‚ฌ
Share price
-1.54%
Change (1 day)
-29.10%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ37.9 Million

According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ37.9 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ33.64 M12.78%
2022-12-31โ‚ฌ29.83 M5.25%
2021-12-31โ‚ฌ28.34 M4.5%
2020-12-31โ‚ฌ27.12 M-11.94%
2019-12-31โ‚ฌ30.8 M-20.04%
2018-12-31โ‚ฌ38.52 M14.64%
2017-12-31โ‚ฌ33.6 M-45.46%
2016-12-31โ‚ฌ61.61 M122.13%
2015-12-31โ‚ฌ27.73 M184.87%
2014-12-31โ‚ฌ9.73 M80.69%
2013-12-31โ‚ฌ5.38 M37.62%
2012-12-31โ‚ฌ3.91 M0.14%
2011-12-31โ‚ฌ3.91 M188.7%
2010-12-31โ‚ฌ1.35 M-17.56%
2009-12-31โ‚ฌ1.64 M-51.28%
2008-12-31โ‚ฌ3.37 M40.39%
2007-12-31โ‚ฌ2.4 M27.58%
2006-12-31โ‚ฌ1.88 M-92.91%
2005-12-31โ‚ฌ26.54 M2855.88%
2004-12-31โ‚ฌ0.89 M593.57%
2003-12-31โ‚ฌ0.12 M-86.23%
2002-12-31โ‚ฌ0.94 M-9.38%
2001-12-31โ‚ฌ1.03 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ11.67 M-69.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.81 B 2,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA